Latest Form 4 insider transactions

Agosti Marcello Pignagnoli, Head, Strat. & Port. Dev of Takeda Pharmaceutical Co Ltd, sold 22,957 shares of common stock on August 10, 2026 for $17.10 per share.

Teresa Marie Bitetti, President, OBU of Takeda Pharmaceutical Co Ltd, sold 50,012 shares of common stock on August 10, 2026 for $17.10 per share.

Gary S. Stetz Ii, a Director of Hepion Pharmaceuticals, Inc., purchased 1,000,000 shares of common stock on August 3, 2026 for $0.05 per share.

Elaine Mary Shannon, Pres., Global Supply & Quality of Takeda Pharmaceutical Co Ltd, sold 3,978 shares of common stock on August 10, 2026 for $17.10 per share.

Gary S. Stetz, Interim CEO and a Director of Hepion Pharmaceuticals, Inc., purchased 4,000,000 shares of common stock on August 3, 2026 for $0.05 per share.

Gabriele Ricci, Chief Data & Tech. Officer of Takeda Pharmaceutical Co Ltd, sold 25,088 shares of common stock on August 10, 2026 for $17.10 per share.

Michael J. Purcell, a Director of Hepion Pharmaceuticals, Inc., purchased 4,000,000 shares of common stock on August 3, 2026 for $0.05 per share.

Xin Wan and 1 other reported changes in beneficial ownership of GigaCloud Technology Inc common stock on August 11, 2026.

Lei Wu and 2 others reported changes in beneficial ownership of GigaCloud Technology Inc common stock on August 10, 2026.

Sireesh Appajosyula, Chief Operating Officer and a Director of Hepion Pharmaceuticals, Inc., purchased 4,000,000 shares of common stock on August 3, 2026 for $0.05 per share.

Marshall Bernes, Head of Brand Center and a Director of GigaCloud Technology Inc, sold 5,000 shares of common stock on August 10, 2026 for $51.88 per share.

Iman Aj Schrock, President of GigaCloud Technology Inc, sold 6,679 shares of common stock on August 10, 2026.

Vincent S Lopriore, Executive Chairman and a Director of Hepion Pharmaceuticals, Inc., purchased 20,000,000 shares of common stock on August 3, 2026 for $0.05 per share.

Shuo Zhang, a Director of Pdf Solutions Inc, sold 1,501 shares of common stock on August 12, 2026 for $51.47 per share.

Garo H Armen, See Remarks and a Director of Agenus Inc, received 1,971,500 shares of common stock on August 10, 2026.

Nicola Deidre Petal Greenway, Chief Human Resources Officer of Takeda Pharmaceutical Co Ltd, sold 6,774 shares of common stock on August 10, 2026 for $17.10 per share.

Julie So-Young Kim, President and CEO and a Director of Takeda Pharmaceutical Co Ltd, sold 89,090 shares of common stock on August 10, 2026 for $17.10 per share.

Giles Richard Platford, President, IBU of Takeda Pharmaceutical Co Ltd, sold 31,083 shares of common stock on August 10, 2026 for $17.10 per share.

Irving Tan, Chief Executive Officer and a Director of Western Digital Corp, sold 20,000 shares of common stock on August 11, 2026.

Natalie Anne Marie Furney, Global General Counsel of Takeda Pharmaceutical Co Ltd, sold 30,868 shares of common stock on August 10, 2026 for $17.10 per share.

Angeliki Frangou, See Remarks, a Director and 10% owner of Navios Maritime Partners L.P., purchased 3,169 shares of common stock on August 10, 2026.

Teddie Benjamin Wardi, a Director of Hinge Health, Inc., reported a transaction in 4,637 shares of common stock on August 10, 2026.

Reza Taleghani, Chief Financial Officer of Under Armour, Inc., purchased 18,656 shares of common stock on August 11, 2026 for $5.37 per share.

Javier Olivan, Chief Operating Officer of Meta Platforms, Inc., sold 1,692 shares of common stock on August 10, 2026.

Todd G. Schwartz, Chief Executive Officer, a Director and 10% owner of OppFi Inc., purchased 60,000 shares of common stock on August 12, 2026 for $7.05 per share.

Todd M. Schneider, CEO and Director and a Director of Cintas Corp, reported multiple transactions in common stock on August 10, 2026.

George Kurtz, PRESIDENT AND CEO and a Director of CrowdStrike Holdings, Inc., sold 20,000 shares of common stock on August 10, 2026.

Scott D Farmer, Executive Chairman and a Director of Cintas Corp, reported multiple transactions in common stock on August 10, 2026.

Scott Garula, EVP & CFO of Cintas Corp, reported multiple transactions in common stock on August 10, 2026.

David Brock Denton, EVP, Secretary & Gen Counsel of Cintas Corp, reported multiple transactions in common stock on August 10, 2026.